ABERNETHY MATT sold NBIX
February 12, 2026 · Form 4 insider transaction
ABERNETHY MATT sold 1,151 shares of Neurocrine Biosciences, Inc. at $123.10 per share, a transaction worth $141.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,151
Price
$123.10
Total value
$141.7K
InsiderABERNETHY MATT
RoleDirector
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after38,079
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of restricted stock units ("RSUs") or performance restricted stock units ("PRSUs"), as applicable. No shares were sold.